Is Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events?
Open Access
- 21 December 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (24) , e022240
Abstract
Background: We investigated whether blood pressure lowering for secondary prevention is associated with a reduction in recurrent stroke risk and/or a higher risk of adverse events in very elderly compared with younger trial participants. Methods and Results: This is a random effects meta‐analysis of randomized controlled trials of blood pressure lowering for secondary stroke prevention to evaluate age‐stratified (2 =49%), and the magnitude of risk reduction did not differ by age subgroup (2 =0%), but there was an increased risk in those ≥80 years (RR, 2.17 [95% CI, 1.22], 3.86, I 2 =0%). No increase was observed in the risk of falls, syncope, study withdrawal, or falls in either age subgroup. Conclusions: Very elderly people in secondary prevention trials of blood pressure lowering have an increased risk of hypotensive symptoms, but with no statistical increase in the risk of falls, syncope, or mortality. However, evidence is lacking for frail elderly with multiple comorbidities who may be more vulnerable to adverse effects of blood pressure lowering.Keywords
This publication has 41 references indexed in Scilit:
- Blood pressure and falls in community-dwelling people aged 60 years and older in the VHM&PP cohortBMC Geriatrics, 2013
- Barriers to achieving blood pressure treatment targets in elderly hypertensive individualsJournal of Human Hypertension, 2013
- Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the ElderlyHypertension, 2010
- Role of Frailty in Patients With Cardiovascular DiseaseThe American Journal of Cardiology, 2009
- Telmisartan to Prevent Recurrent Stroke and Cardiovascular EventsNew England Journal of Medicine, 2008
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialThe Lancet, 2007
- Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical JournalsJAMA, 2007
- Hypertension in Adults Across the Age SpectrumJAMA, 2005
- Blood Pressure and StrokeStroke, 2004
- Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke. The Dutch TIA Trial Study Group.Stroke, 1993